Multiplex STI Pathogen Detection Kit With Lateral Flow Readout

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current molecular diagnostic methods for sexually transmitted infections (STIs) are cumbersome, prone to human error, expensive, or require costly equipment, limiting their effectiveness and accessibility.

Innovation Solution

A kit using primers and probes that bind specifically to STI-causing pathogens, enabling simultaneous detection of 12 pathogens through multiplex PCR and lateral flow assay, eliminating the need for expensive devices and complex electrophoresis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional PCR-electrophoresis method is used, then detection accuracy is maintained, but process complexity increases and human error occurs

Engineering Contradiction:
Improvedetection accuracyVSAvoidprocess complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent extracts the electrophoresis step from the conventional PCR-diagnosis workflow and replaces it with a lateral flow assay system. The detection function is separated into specific binding components (probes attached to gold particles) that directly visualize results without requiring electrophoresis equipment or gel analysis, thereby simplifying the process while maintaining detection accuracy.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces gold particles as an intermediary carrier that binds to specific nucleic acid probes. This intermediary system enables direct visualization of detection results through color changes on a lateral flow membrane, eliminating the need for complex electrophoresis equipment and reducing human error in result interpretation while preserving detection reliability.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If real-time PCR method is used, then detection speed is improved, but equipment cost and kit cost increase

Engineering Contradiction:
Improvedetection speedVSAvoidequipment cost
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent employs disposable lateral flow assay components including pre-prepared gold particles conjugated with specific probes, single-use test membranes, and disposable sample application cards. This eliminates the need for expensive real-time PCR equipment while maintaining rapid detection capability, as each test is self-contained and requires no sophisticated instrumentation.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent replaces the mechanical/optical detection system of real-time PCR (requiring expensive thermal cyclers and fluorescent detectors) with a simple lateral flow capillary action system. The detection is based on passive fluid movement and visual color changes, substituting complex mechanical systems with simple physical principles that reduce equipment costs while preserving detection speed.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If conventional PCR-electrophoresis method is used, then detection reliability is maintained, but detection time increases

Engineering Contradiction:
Improvedetection reliabilityVSAvoiddetection time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent performs preliminary conjugation of specific nucleic acid probes to gold particles during manufacturing, creating pre-ready detection reagents. This preliminary action eliminates the need for time-consuming in-lab probe preparation and electrophoresis setup, allowing rapid detection while maintaining reliability through pre-validated specific binding pairs.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent skips the time-consuming electrophoresis separation and gel visualization steps by directly implementing specific probe-gold particle binding followed by lateral flow visualization. This rushes through the detection process by eliminating intermediate steps while preserving detection reliability through the specificity of nucleic acid hybridization and visual confirmation.

Inventive Principle:
Principle #21Skipping (Rushing through)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The kit provides rapid, accurate, and cost-effective detection of multiple STIs with trace samples, reducing human error and equipment costs.

Implementation Method 1

a complementary nucleic acid oligomer capable of binding to and amplifying a gene specific to a sexually transmitted infection-causing pathogen

Methodology Applied
Scientific EffectComplementary base pairing:

Implementation Method 2

a probe that binds complementary to the non-complementary nucleic acid oligomer

Methodology Applied
Scientific EffectComplementary base pairing:

Data Source

PatentUS20250270664A1Kit for detecting pathogens causing sexually transmitted infections and method for detecting pathogens causing sexually transmitted infections using same
Publication Date: 2025.08.28 PAXGENBIO CO LTD
  • US20250270664A1 patent drawing
  • US20250270664A1 patent drawing
  • US20250270664A1 patent drawing

AI summary

The present invention relates to a kit for detecting sexually transmitted infection-causing pathogens selected from the group consisting of 12 sexually transmitted infection (STI)-causing pathogens, including Chlamydia trachomatis (CT), Neisseria gonorrhea (NG), Treponema pallidum (TP), Trichomonas vaginalis (TV), Ureaplasma urealyticum (UU), Ureaplasma parvum (UP), Mycoplasma genitalium (MG), Mycoplasma hominis (MH), Gardnerella vaginalis (GV), Candida albicans (CA), Herpes simplex virus 1 (HSV1), and Herpes simplex virus 2 (HSV2), and a method of detecting sexually transmitted infection-causing pathogens using the same.